Your browser is no longer supported. Please, upgrade your browser.
Settings
HSAC Health Sciences Acquisitions Corporation daily Stock Chart
HSAC [NASD]
Health Sciences Acquisitions Corporation
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand14.38M Perf Week14.20%
Market Cap166.46M Forward P/E- EPS next Y- Insider Trans- Shs Float2.35M Perf Month13.86%
Income- PEG- EPS next Q- Inst Own- Short Float5.13% Perf Quarter16.97%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.71 Perf Half Y-
Book/sh1.42 P/B8.18 EPS next Y- ROA- Target Price- Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range9.57 - 11.49 Perf YTD16.38%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High0.78% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low21.00% ATR0.33
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)84.49 Volatility5.57% 2.99%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.40 Prev Close11.12
ShortableNo LT Debt/Eq- Earnings- Payout- Avg Volume169.16K Price11.58
Recom- SMA2011.36% SMA5012.87% SMA20014.56% Volume237,229 Change4.14%
Dec-02-19 08:00AM  Health Sciences Acquisitions Corporation Sets Date for Special Meeting of Stockholders to Vote on Transaction with Immunovant Sciences Ltd. GlobeNewswire
Oct-08-19 07:00AM  Health Sciences Acquisitions Corporation and Immunovant to Host Joint Conference Call for the Investment Community on Friday, October 11, at 8:30am EDT PR Newswire
Oct-02-19 07:00AM  Immunovant to Merge with Health Sciences Acquisitions Corporation, Creating New Publicly Listed FcRn-Focused Company PR Newswire
Health Sciences Acquisitions Corporation focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the healthcare and healthcare-related industries in North America or Europe. The company was founded in 2018 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WONG RODERICKChief Executive OfficerDec 11Buy10.9231,500344,024902,498Dec 13 06:00 PM
WONG RODERICKChief Executive OfficerDec 10Buy10.3825,971269,517870,998Dec 10 06:22 PM
WONG RODERICKChief Executive OfficerDec 06Buy10.2050,000510,125845,027Dec 09 05:01 PM
WONG RODERICKChief Executive OfficerDec 06Buy10.25400,0004,100,000795,027Dec 09 07:31 AM
WONG RODERICKChief Executive OfficerDec 05Buy10.1520,000203,000395,027Dec 05 06:07 PM
WONG RODERICKChief Executive OfficerDec 04Buy10.1520,000203,000375,027Dec 04 06:33 PM
WONG RODERICKChief Executive OfficerDec 03Buy10.2120,000204,200355,027Dec 03 05:42 PM
WONG RODERICKChief Executive OfficerDec 02Buy10.4020,000208,000335,027Dec 03 05:42 PM
WONG RODERICKChief Executive OfficerNov 29Buy10.4526,918281,293315,027Dec 03 05:42 PM
WONG RODERICKChief Executive OfficerNov 27Buy10.484,00041,904288,109Nov 29 01:00 PM
WONG RODERICKChief Executive OfficerNov 26Buy10.494,00041,960284,109Nov 29 01:00 PM
WONG RODERICKChief Executive OfficerNov 25Buy10.504,00042,000280,109Nov 29 01:00 PM
WONG RODERICKChief Executive OfficerNov 22Buy10.542,00021,080276,109Nov 22 05:42 PM
WONG RODERICKChief Executive OfficerNov 21Buy10.4215,194158,299274,109Nov 22 05:42 PM
WONG RODERICKChief Executive OfficerNov 20Buy10.3929,805309,582258,915Nov 22 05:42 PM
WONG RODERICKChief Executive OfficerNov 19Buy10.2529,805305,501229,110Nov 19 06:06 PM
WONG RODERICKChief Executive OfficerNov 18Buy10.2529,805305,501199,305Nov 19 06:06 PM
WONG RODERICKChief Executive OfficerNov 15Buy10.2913,000133,800169,500Nov 19 06:06 PM
WONG RODERICKChief Executive OfficerNov 14Buy10.1713,000132,210156,500Nov 14 05:51 PM
WONG RODERICKChief Executive OfficerNov 13Buy10.1713,000132,210143,500Nov 14 05:51 PM
WONG RODERICKChief Executive OfficerNov 12Buy10.17100,0001,017,000130,500Nov 14 05:51 PM